Sepalika.com, a content platform that supports those looking to reverse chronic health conditions through guidance on lifestyle, dietary supplements and exercise, has raised $750,000 in its seed round. The funding round was led by Accel for which the healthcare space is a key sector at the moment. Sepalika aims to use the fresh capital infused for further building on its research-based content and strengthening its core proposition in the key market of USA.
Sepalika is the brainchild of Sharda Agarwal and Mahesh Jayaraman whose sole aim is to help people manage their chronic health conditions in the most effective way, reducing the need for medications as their health improves. Its vision is to empower patients with the right knowledge and transform lives. The duo believes that the incidence of chronic health conditions is rising globally, yet most people are not aware that these conditions can be managed or reversed through diet and lifestyle changes as well as supplements. With not enough websites dedicated to treating chronic illnesses, a growing space with limited solutions makes Sepalika an attractive business model and has been fundamental in helping it secure this round of funding.
Sepalika spokesperson, Ms. Sharda Agarwal Co-founder, Sepalika, said, “At Sepalika, we’re committed to helping patients alleviate their suffering through simple diet and lifestyle changes, optimal use of dietary supplements and by addressing the side effects their medicines may cause over the long term. Currently, Sepalika focuses on 11 chronic health conditions, including diseases of the heart, type 2 diabetes, acidity, hypertension, arthritis, mental health and depression. Our mission is to transform the lives of people by covering a gamut of disorders and addressing each of them with a 360-degree approach. The latest round of capital raised will help us to further boost the offerings of our platform and inch closer to our overall vision.”
Elaborating further on the funding, Barath Shankar Subramanian, Principal, Accel, commented, “Sepalika is delivering on its mission to transform lives with its unique business model. The research-backed content platform aims to bring down the dependence on drugs and partner patients, caregivers, or experts in functional medicine to reverse chronic illnesses. With people increasingly becoming health-conscious and resorting to natural methods to cure their illnesses, the resources at Sepalika such as use of research-backed dietary supplements, exercise and stress management have a very important role to play in the effort to stay in good health. The platform has tremendous potential to scale and we look forward to working with it towards its larger goal.”
Launched in March 2016, Sepalika makes use of a functional medicine approach to understand the disease at its root cause and address it through a research-backed holistic approach.
Sepalika is the brainchild of Sharda Agarwal and Mahesh Jayaraman whose sole aim is to help people manage their chronic health conditions in the most effective way, reducing the need for medications as their health improves. Its vision is to empower patients with the right knowledge and transform lives. The duo believes that the incidence of chronic health conditions is rising globally, yet most people are not aware that these conditions can be managed or reversed through diet and lifestyle changes as well as supplements. With not enough websites dedicated to treating chronic illnesses, a growing space with limited solutions makes Sepalika an attractive business model and has been fundamental in helping it secure this round of funding.
Sepalika spokesperson, Ms. Sharda Agarwal Co-founder, Sepalika, said, “At Sepalika, we’re committed to helping patients alleviate their suffering through simple diet and lifestyle changes, optimal use of dietary supplements and by addressing the side effects their medicines may cause over the long term. Currently, Sepalika focuses on 11 chronic health conditions, including diseases of the heart, type 2 diabetes, acidity, hypertension, arthritis, mental health and depression. Our mission is to transform the lives of people by covering a gamut of disorders and addressing each of them with a 360-degree approach. The latest round of capital raised will help us to further boost the offerings of our platform and inch closer to our overall vision.”
Elaborating further on the funding, Barath Shankar Subramanian, Principal, Accel, commented, “Sepalika is delivering on its mission to transform lives with its unique business model. The research-backed content platform aims to bring down the dependence on drugs and partner patients, caregivers, or experts in functional medicine to reverse chronic illnesses. With people increasingly becoming health-conscious and resorting to natural methods to cure their illnesses, the resources at Sepalika such as use of research-backed dietary supplements, exercise and stress management have a very important role to play in the effort to stay in good health. The platform has tremendous potential to scale and we look forward to working with it towards its larger goal.”
Launched in March 2016, Sepalika makes use of a functional medicine approach to understand the disease at its root cause and address it through a research-backed holistic approach.
Advertisements